111, Inc. (YI)
NASDAQ: YI · Real-Time Price · USD
4.536
+0.136 (3.09%)
Oct 21, 2025, 4:00 PM EDT - Market closed
111, Inc. Market Cap
111, Inc. has a market cap or net worth of $39.32 million as of October 22, 2025. Its market cap has decreased by -42.17% in one year.
Market Cap
39.32M
Enterprise Value
6.57M
1-Year Change
-42.17%
Ranking
Category
Stock Price
$4.54
Market Cap Chart
Since September 12, 2018, 111, Inc.'s market cap has decreased from $1.11B to $39.32M, a decrease of -96.47%. That is a compound annual growth rate of -37.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 20, 2025 | 38.14M | -28.54% |
| Dec 31, 2024 | 53.37M | -59.01% |
| Dec 29, 2023 | 130.19M | -48.23% |
| Dec 30, 2022 | 251.48M | -13.30% |
| Dec 31, 2021 | 290.06M | -49.33% |
| Dec 31, 2020 | 572.40M | 4.16% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Sep 12, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 717.80B |
| Johnson & Johnson | 462.11B |
| AbbVie | 408.76B |
| UnitedHealth Group | 330.91B |
| AstraZeneca | 259.08B |
| Novartis AG | 254.71B |
| Novo Nordisk | 245.28B |
| Abbott Laboratories | 221.98B |